NEPHROGENEX

Serial Number 86692063
606

Registration Progress

Application Filed
Jul 14, 2015
Under Examination
Aug 30, 2016
Approved for Publication
Jul 5, 2016
Published for Opposition
Jul 5, 2016
Registered

Basic Information

Serial Number
86692063
Filing Date
July 14, 2015
Published for Opposition
July 5, 2016
Abandonment Date
October 2, 2017
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 2, 2017
Classes
005

Rights Holder

NephroGenex, Inc.

03
Address
3200 Beechleaf Court
Suite 900
Raleigh, NC 27604

Ownership History

NephroGenex, Inc.

Original Applicant
03
Raleigh, NC

NephroGenex, Inc.

Owner at Publication
03
Raleigh, NC

Legal Representation

Attorney
David Harper

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

22 events
Date Code Type Description
Oct 2, 2017 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Oct 2, 2017 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 24, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 22, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 22, 2017 EXT1 S SOU EXTENSION 1 FILED
Feb 22, 2017 EX1G S SOU EXTENSION 1 GRANTED
Aug 30, 2016 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 5, 2016 PUBO A PUBLISHED FOR OPPOSITION
Jul 5, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 15, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 2, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
May 26, 2016 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2016 ALIE A ASSIGNED TO LIE
Apr 26, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 27, 2015 CNRT R NON-FINAL ACTION WRITTEN
Oct 27, 2015 GNRT F NON-FINAL ACTION E-MAILED
Oct 27, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 23, 2015 DOCK D ASSIGNED TO EXAMINER
Jul 17, 2015 NWAP I NEW APPLICATION ENTERED
Jul 17, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 005
Human pharmaceutical preparations for the treatment of diabetic complications, namely, diabetic nephropathy
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005